Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:RTGN)

3.750 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.750
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 3.750
Today's Range 3.750 - 3.750
52wk Range 1.600 - 6.360
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire

Performance

YTD
-41.0%
-41.0%
1 Month
+5.9%
+5.9%
3 Month
+5.9%
+5.9%
6 Month
+5.9%
+5.9%
1 Year
+134.4%
+134.4%

More News

Read More
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is RTGN publicly traded?
Yes, RTGN is publicly traded.
What exchange does RTGN trade on?
RTGN trades on the OTC Traded
What is the ticker symbol for RTGN?
The ticker symbol for RTGN is RTGN on the OTC Traded
What is the current price of RTGN?
The current price of RTGN is 3.750
When was RTGN last traded?
The last trade of RTGN was at 10/27/25 03:58 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.